This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Lung Cancer
  • /
  • The impact of body mass index on the efficacy of a...

The impact of body mass index on the efficacy of anti-PD-1/PD-L1 antibodies in patients with non-small cell lung cancer

Read time: 1 mins
Published:31st Dec 2019
Author: Ichihara E, Harada D, Inoue K, Sato K, Hosokawa S, Kishino D et al.
Source: Lung Cancer
Availability: Pay for access, or by subscription
Ref.:Lung Cancer. 2020 Jan;139:140-145.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest